RetroSearch Browse

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/37019620/ below:

Joint Asian Pacific Association of Gastroenterology (APAGE)-Asian Pacific Society of Digestive Endoscopy (APSDE) clinical practice guidelines on the use of non-invasive biomarkers for diagnosis of colorectal neoplasia

. 2023 Jul;72(7):1240-1254. doi: 10.1136/gutjnl-2023-329429. Epub 2023 Apr 5. Joint Asian Pacific Association of Gastroenterology (APAGE)-Asian Pacific Society of Digestive Endoscopy (APSDE) clinical practice guidelines on the use of non-invasive biomarkers for diagnosis of colorectal neoplasia Martin C S Wong^#^{2 3}, Andrew T Chan^{4 5 6}, James E East^{7 8}, Han-Mo Chiu⁹, Govind K Makharia¹⁰, David Weller¹¹, Choon Jin Ooi¹², Julajak Limsrivilai¹³, Yutaka Saito¹⁴, Dao V Hang¹⁵, Jon D Emery¹⁶, Dadang Makmun¹⁷, Kaichun Wu¹⁸, Raja Affendi Raja Ali¹⁹, Siew C Ng²⁰

Affiliations

¹ Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, People's Republic of China.
² JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, People's Republic of China.
³ Centre for Health Education and Health Promotion, The Chinese University of Hong Kong, Hong Kong, People's Republic of China.
⁴ Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
⁵ Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
⁶ Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
⁷ Translational Gastroenterology Unit, Nuffield Department of Medicine, Oxford NIHR Biomedical Research Centre, John Radcliffe Hospital, University of Oxford, Oxford, UK.
⁸ Division of Gastroenterology and Hepatology, Mayo Clinic Healthcare, London, UK.
⁹ Department of Internal Medicine, College of Medicine, National Taiwan University Hospital, Taipei, Taiwan.
¹⁰ Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India.
¹¹ Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh Usher Institute of Population Health Sciences and Informatics, Edinburgh, UK.
¹² Duke - NUS Medical School, Singapore.
¹³ Internal Medicine, Mahidol University Faculty of Medicine Siriraj Hospital, Bangkok, Thailand.
¹⁴ Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
¹⁵ Hanoi Medical University, Hanoi, Vietnam.
¹⁶ Department of General Practice, The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia.
¹⁷ University of Indonesia, Depok, Indonesia.
¹⁸ Xijing Hospital of Digestive Diseases, Xijing Hospital, Xian, China siewchienng@cuhk.edu.hk draffendi@ppukm.ukm.edu.my kaicwu@fmmu.edu.cn.
¹⁹ School of Medical and Life Sciences Sunway University, Selangor, Malaysia siewchienng@cuhk.edu.hk draffendi@ppukm.ukm.edu.my kaicwu@fmmu.edu.cn.
²⁰ Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, People's Republic of China siewchienng@cuhk.edu.hk draffendi@ppukm.ukm.edu.my kaicwu@fmmu.edu.cn.

PMID: 37019620
PMCID: PMC10314015
DOI: 10.1136/gutjnl-2023-329429

Item in Clipboard

Joint Asian Pacific Association of Gastroenterology (APAGE)-Asian Pacific Society of Digestive Endoscopy (APSDE) clinical practice guidelines on the use of non-invasive biomarkers for diagnosis of colorectal neoplasia

Francis K L Chan et al. Gut. 2023 Jul.

. 2023 Jul;72(7):1240-1254. doi: 10.1136/gutjnl-2023-329429. Epub 2023 Apr 5. Authors Francis K L Chan^#¹, Martin C S Wong^#^{2 3}, Andrew T Chan^{4 5 6}, James E East^{7 8}, Han-Mo Chiu⁹, Govind K Makharia¹⁰, David Weller¹¹, Choon Jin Ooi¹², Julajak Limsrivilai¹³, Yutaka Saito¹⁴, Dao V Hang¹⁵, Jon D Emery¹⁶, Dadang Makmun¹⁷, Kaichun Wu¹⁸, Raja Affendi Raja Ali¹⁹, Siew C Ng²⁰ Affiliations

¹ Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, People's Republic of China.
² JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, People's Republic of China.
³ Centre for Health Education and Health Promotion, The Chinese University of Hong Kong, Hong Kong, People's Republic of China.
⁴ Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
⁵ Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
⁶ Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
⁷ Translational Gastroenterology Unit, Nuffield Department of Medicine, Oxford NIHR Biomedical Research Centre, John Radcliffe Hospital, University of Oxford, Oxford, UK.
⁸ Division of Gastroenterology and Hepatology, Mayo Clinic Healthcare, London, UK.
⁹ Department of Internal Medicine, College of Medicine, National Taiwan University Hospital, Taipei, Taiwan.
¹⁰ Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India.
¹¹ Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh Usher Institute of Population Health Sciences and Informatics, Edinburgh, UK.
¹² Duke - NUS Medical School, Singapore.
¹³ Internal Medicine, Mahidol University Faculty of Medicine Siriraj Hospital, Bangkok, Thailand.
¹⁴ Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
¹⁵ Hanoi Medical University, Hanoi, Vietnam.
¹⁶ Department of General Practice, The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia.
¹⁷ University of Indonesia, Depok, Indonesia.
¹⁸ Xijing Hospital of Digestive Diseases, Xijing Hospital, Xian, China siewchienng@cuhk.edu.hk draffendi@ppukm.ukm.edu.my kaicwu@fmmu.edu.cn.
¹⁹ School of Medical and Life Sciences Sunway University, Selangor, Malaysia siewchienng@cuhk.edu.hk draffendi@ppukm.ukm.edu.my kaicwu@fmmu.edu.cn.
²⁰ Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, People's Republic of China siewchienng@cuhk.edu.hk draffendi@ppukm.ukm.edu.my kaicwu@fmmu.edu.cn.

PMID: 37019620
PMCID: PMC10314015
DOI: 10.1136/gutjnl-2023-329429

Item in Clipboard

Abstract

Screening for colorectal cancer (CRC) is effective in reducing CRC related mortality. Current screening methods include endoscopy based and biomarker based approaches. This guideline is a joint official statement of the Asian Pacific Association of Gastroenterology (APAGE) and the Asian Pacific Society of Digestive Endoscopy (APSDE), developed in response to the increasing use of, and accumulating supportive evidence for the role of, non-invasive biomarkers for the diagnosis of CRC and its precursor lesions. A systematic review of 678 publications and a two stage Delphi consensus process involving 16 clinicians in various disciplines was undertaken to develop 32 evidence based and expert opinion based recommendations for the use of faecal immunochemical tests, faecal based tumour biomarkers or microbial biomarkers, and blood based tumour biomarkers for the detection of CRC and adenoma. Comprehensive up-to-date guidance is provided on indications, patient selection and strengths and limitations of each screening tool. Future research to inform clinical applications are discussed alongside objective measurement of research priorities. This joint APAGE-APSDE practice guideline is intended to provide an up-to-date guide to assist clinicians worldwide in utilising non-invasive biomarkers for CRC screening; it has particular salience for clinicians in the Asia-Pacific region.

Keywords: clinical decision making; colorectal cancer; screening; tumour markers.

PubMed Disclaimer

Conflict of interest statement

Competing interests: FKLC is Board Member of CUHK Medical Centre. He is a co-founder, non-executive Board Chairman and shareholder of GenieBiome Ltd. He receives patent royalties through his affiliated institutions. He has received fees as an advisor and honoraria as a speaker for Eisai Co. Ltd., AstraZeneca, Pfizer Inc., Takeda Pharmaceutical Co., and Takeda (China) Holdings Co. Ltd. MCSW is the honorary medical advisor of GenieBiome. He is an advisory committee member of Pfizer, external expert of GlaxoSmithKline, a member of the advisory board of AstraZeneca and has been paid consultancy fees for providing advice on research. ATC is a member of the AGA Governing Board and has received grant funding from Freenome for a colorectal cancer screening study. HM-C is the principal investigator, Taiwan CRC Screening Program, Asian Chair of WEO CRC screening committee and secretary general of the Gastroenterological Society of Taiwan (GEST), received research funding from Volition Rx, Eiken Chemical and Aether AI, and lecture honorarium from Olympus, Fuji and Eiken Chemical. JEE has served on clinical advisory boards for Paion, has served on the clinical advisory board and has share options in Satisfai Health and reports speaker fees from Falk, Jannsen and Medtronic. He was also part of the British Society of Gastroenterology guideline working group for 'Faecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC)'. He is funded by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR or the Department of Health. KW has served as an advisory board member for BioChain (Beijing), Ferring, Janssen, Takeda and Abbvie, and a speaker for BioChain (Beijing), Ferring, Janssen, Abbvie, Everest and Takeda. He is named inventor of patent applications held by the FMMU and BioChain (Beijing) that cover the diagnostic use of ctDNA related to gastrointestinal cancers. SCN has served as an advisory board member for Pfizer, Ferring, Janssen, and Abbvie and received honoraria as a speaker for Ferring, Tillotts, Menarini, Janssen, Abbvie, and Takeda. SCN has received research grants through her affiliated institutions from Olympus, Ferring, and Abbvie. SCN is a scientific co-founder and shareholder of GenieBiome Ltd. SCN receives patent royalties through her affiliated institutions.